Theophylline to treat prolonged paroxysmal complete atrioventricular block without conduction disorder or structural heart disease after COVID-19 infection: A case report

Hondo, Haruka; Kowase, Shinya; Asano, Shunichi; Osada, Jun; Aoki, Hajime; Yumoto, Kazuhiko

doi:10.1016/j.hrcr.2021.12.020

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

2024

Publication Types

Select...

Preprint1

Article1

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The drugs used there decrease vagal nerve activity -like atropine and its derivative or stimulate sympathetic nervous system like salbutamol [42]. There are also reports on methylxanthines -theophylline and aminophylline (a theophylline derivative) with positive effects in CHB [43].…”

Section: Discussionmentioning

confidence: 99%

Congenital Complete Heart Block—To Stimulate (When?) or Not to Stimulate?

Kukla,

Podlejska,

Wiliński

2024

Preprint

View full text Add to dashboard Cite

The article presents the case of a 27-year-old female patient with idiopathic congenital complete heart block who was referred by her primary care physician for cardiological evaluation. The conduction disturbance was recognized at the age of 6 years and was asymptomatic. The disqualification from pacemaker implantation included detailed history of a patient’s symptoms, echocardiographic assessment of the heart, exercise testing and ECG Holter monitoring. The aid of salbutamol administered orally was also useful.

show abstract

Section: Discussionmentioning

confidence: 99%